These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20065949)

  • 1. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
    Chou JL; Su HY; Chen LY; Liao YP; Hartman-Frey C; Lai YH; Yang HW; Deatherage DE; Kuo CT; Huang YW; Yan PS; Hsiao SH; Tai CK; Lin HJ; Davuluri RV; Chao TK; Nephew KP; Huang TH; Lai HC; Chan MW
    Lab Invest; 2010 Mar; 90(3):414-25. PubMed ID: 20065949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
    Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
    Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
    Yuan X; Zhang Z; Jiang K; Wang X; Li Y
    Med Sci Monit; 2018 Feb; 24():1080-1088. PubMed ID: 29465067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.
    Yeh KT; Chen TH; Yang HW; Chou JL; Chen LY; Yeh CM; Chen YH; Lin RI; Su HY; Chen GC; Deatherage DE; Huang YW; Yan PS; Lin HJ; Nephew KP; Huang TH; Lai HC; Chan MW
    Epigenetics; 2011 Jun; 6(6):727-39. PubMed ID: 21540640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer.
    Zhang YW; Zheng Y; Wang JZ; Lu XX; Wang Z; Chen LB; Guan XX; Tong JD
    Epigenetics; 2014 Jun; 9(6):896-909. PubMed ID: 24699858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF; Dai DQ; Guo KJ
    Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.
    Sakuma M; Akahira J; Ito K; Niikura H; Moriya T; Okamura K; Sasano H; Yaegashi N
    Cancer Sci; 2007 Mar; 98(3):380-6. PubMed ID: 17270028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
    Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
    Fiskus W; Rao R; Balusu R; Ganguly S; Tao J; Sotomayor E; Mudunuru U; Smith JE; Hembruff SL; Atadja P; Marquez VE; Bhalla K
    Clin Cancer Res; 2012 Nov; 18(22):6227-38. PubMed ID: 22932665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
    Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
    BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer.
    Chan MW; Huang YW; Hartman-Frey C; Kuo CT; Deatherage D; Qin H; Cheng AS; Yan PS; Davuluri RV; Huang TH; Nephew KP; Lin HJ
    Neoplasia; 2008 Sep; 10(9):908-19. PubMed ID: 18714391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
    Quan J; Ma C
    Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy.
    Cai Y; An B; Yao D; Zhou H; Zhu J
    Bioengineered; 2021 Dec; 12(2):10713-10722. PubMed ID: 34747309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.
    Tian H; Yan L; Xiao-Fei L; Hai-Yan S; Juan C; Shan K
    Clin Epigenetics; 2019 Oct; 11(1):153. PubMed ID: 31666131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.
    Meng F; Sun G; Zhong M; Yu Y; Brewer MA
    Br J Cancer; 2013 Feb; 108(3):579-86. PubMed ID: 23370212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.
    Steele N; Finn P; Brown R; Plumb JA
    Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis.
    Liao X; Li Z; Zheng H; Qian W; Zhang S; Chen S; Li X; Tang M; Xu Y; Yu R; Li M; Song L; Li J
    Mol Cancer Res; 2023 Jul; 21(7):648-663. PubMed ID: 36961398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.